BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 649228)

  • 1. The bioavailability of alpha-acetyldigoxin from Card-Hydergin--a fixed combination of Hydergine and acetyldigoxin.
    Klotz U
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):116-8. PubMed ID: 649228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations.
    Woodcock BG; Habedank WD; Loh W; Herrmann W; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):660-3. PubMed ID: 3436686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Absolute bioavailability of beta-acetyldigoxin from tablets and drops in healthy subjects].
    Dreyer M; Dammann HG; Endell W; Rudolph M; Iven H
    Arzneimittelforschung; 1992 Mar; 42(3):303-6. PubMed ID: 1497688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of bioavailability and enteral absorption of digoxin, beta-acetyldigoxin and beta-methhyldigoxin. Measurement of cumulative renal excretion after a single application (author's transl)].
    Greeff K; Hafner D; Strobach H; Wirth KE
    Arzneimittelforschung; 1977; 27(12):2358-64. PubMed ID: 580051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Isomerisation and bioavailability of beta- and alpha-acetyldigoxin (author's transl)].
    Rietbrock N; Vöhringer HF; Kuhlmann J; Maertin K
    Klin Wochenschr; 1977 Jul; 55(13):641-6. PubMed ID: 895002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of digoxin tablets.
    Beveridge T; Nüesch E; Ohnhaus EE
    Arzneimittelforschung; 1978; 28(4):701-3. PubMed ID: 581950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability of beta-acetyldigoxin and digoxin (author's transl)].
    Flasch H
    Klin Wochenschr; 1975 Sep; 53(18):873-7. PubMed ID: 1172599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bio-availability of beta-acetyldigoxine (Novodigal) alone and combined with oxyfedrine (Ildamen-Novodigal).
    Bonelli J; Hruby K; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):288-93. PubMed ID: 881282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of beta-acetyldigoxin after single and repeated doses of tablets and solution.
    Klotz U; Antonin KH; Bieck PR
    Eur J Clin Pharmacol; 1976; 10(6):417-24. PubMed ID: 1001357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative bioavailability of three pharmaceutical forms of digoxin].
    Thebault J; Lucas A; d'Athis P; Tillement JP
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):144-7. PubMed ID: 576592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of Dilanacin and Dilanacin new].
    Sorger D; Gruber G
    Z Gesamte Inn Med; 1982 Dec; 37(24):849-53. PubMed ID: 7170822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the absolute bioavailability of four oral digoxin preparations (author's transl)].
    Rietbrock N; Alken RG; Ebert W
    Arzneimittelforschung; 1979; 29(11):1742-5. PubMed ID: 583489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bioavailability of Redergin tablets (1.0 mg) and Redergin solution.
    Kopitar Z; Milovac J; Vrhovac B; Tadjer I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):134-8. PubMed ID: 7068286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and pharmacokinetic profile of dihydroergotoxine from a tablet and from an oral solution formulation.
    Setnikar I; Schmid K; Rovati LC; Vens-Cappell B; Mazur D; Kozak I
    Arzneimittelforschung; 2001 Jan; 51(1):2-6. PubMed ID: 11215321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1976; 26(12):2208-13. PubMed ID: 1037278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.